Circling the drain - Software Developer Meditech Employee Review

2.0
Aug 8, 2022
Recommend
CEO approval
Business Outlook

Pros

Longevity Great people to work with Great Peers

Cons

Pay is awful Benefits slowly being taken away Constant Employee Tracking Gaslighting Employees on Everything Constant Flip Flop of Work at Home guidelines leads to no one knowing what is going on CEO wants people in the office so they can work with their groups, but groups are dispersed across five buildings and no one is in on the same day, so why make us go in to work with each other, if you're going to be the only one there. Yearly bonus has been whittled down to nothing No longer offering stock - company did a mandatory stock buy back if you had less than 5000 shares, so only the top tier are getting dividends. CONSTANT self evaluations (at least quarterly) that all go in written permanent file. Out of nowhere, they demand everyone get mandatory background checks Constant re-orgs, they split a team of six, and move three to a new platform, then complain when the output of the group goes down. Seems like there are more Associate Vice Presidents and higher than Directors or Managers. Every year they would post how great Q4 earnings were, then when bonus and raise time came, we were told a different story. Company seems more interested in looking diverse than being diverse.

Explore other reviews about Meditech

5.0
Nov 23, 2025
Recommend
CEO approval
Business Outlook

Pros

Pretty good environment to work in

Cons

A lot of travel which is both good and bad

2.0
Jul 12, 2026
Recommend
CEO approval
Business Outlook

Pros

MEDITECH is surviving, which wasn't a certainty ten years ago. Considering the low starting salaries for greater Boston, the company tends to be less selective in who they hire compared to other employers. Even with the effect that AI is having on tech hiring.

Cons

The market was MEDITECH's to lose, and they lost it. Without HCA as a customer MEDITECH would be finished. Considerations for job applicants such as inclusiveness and work/life balance are largely irrelevant, as the company's long-term prospects for success are doubtful. MaaS subscriptions don't bring in enough money to make up for the business that was lost to market leader Epic Systems. I am a MEDITECH shareholder, so I see the financial reports. Although I'm pleased that dividends continue to be paid, they are draining the company of badly needed cash to fund a turnaround.

4
See reviews by: Helpful|Rating|Date|All